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Abstract 
Background: Epilepsy is one of the most common neurological conditions in dogs. Despite that epilepsy appears to 
be common in the Rottweiler breed, published literature about the phenotype of epilepsy in this breed is lacking. The 
aim of this questionnaire-based study was to describe the clinical characteristics of epilepsy in the Rottweiler breed 
including; signalment, pedigree, housing conditions and information about the seizures such as age at onset, seizure 
type, duration, and progression, as well as number of seizure days (24 h), effect and side effects of anti-epileptic drugs, 
and potential comorbidities. The diagnosis for epilepsy of unknown origin was based on the following inclusion cri-
teria: ≥2 seizure days, starting between 6 months and 7 years of age, no known history of poisoning or serious head 
trauma, and (when available), pre-study routine serum biochemical parameters were within the reference intervals.
Results: A total of 37 cases (23 females and 14 males) were included in the study. The median age at onset of sei-
zures was 36 months (range 8–84 months). The dogs suffered from generalized tonic–clonic seizures, and more than 
50 % of the dogs had experienced cluster seizures (>1 seizure in 24 h). The dogs commonly started to seizure while 
resting (23/36) and/or sleeping (20/36). Only 3 of the 36 dogs experienced seizures during activities such as walking 
or training. All of the 24/37 (64.9 %) dogs on antiepileptic drugs received phenobarbital. Five dogs needed add-
on treatment (n = 5), and of these: one dog was on 3 drugs (phenobarbital, potassium bromid and levetiracetam) 
(n = 1), three dogs were on phenobarbital and potassium bromide (n = 3), and one dog received phenobarbital 
and imepitoin (n = 1). Seizure frequency did not necessarily improve following antiepileptic treatment, and for six 
of 21 (28.6 %) of the dogs, seizure frequency increased. All of the Rottweilers in this study had relatives with epilepsy 
reported.
Conclusions: The Rottweilers suffering from epilepsy in this study presented with generalized tonic–clonic seizures, 
and their response to antiepileptic treatment was variable. More than 50 % of the dogs had experienced cluster sei-
zures (>1 seizure in 24 h).
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Background
Epilepsy is one of the most common neurological con-
ditions in dogs [1]. The disorder is characterized by 
recurrent seizures originating from the brain, due to an 
imbalance between excitatory and inhibitory mecha-
nisms [2]. Epilepsy has often been divided into sympto-
matic epilepsy (SE), caused by an identifiable structural 
lesion in the brain, and idiopathic epilepsy (IE) with-
out an underlying morphological disease. Dogs with 
IE frequently require lifelong antiepileptic treatment. 
Approximately 20–30 % of dogs with IE do not respond 
to antiepileptic therapy [2], and dogs with epilepsy are 
reported to have an increased risk of premature death, 
most commonly due to euthanasia, if the seizures cannot 
be controlled [3–7].
The prevalence of epilepsy in dogs is difficult to estab-
lish because of variable diagnostic criteria and vaguely 
defined populations at risk, but it was estimated to be 
around 1–2 % in a hospital-based referral population [8] 
and 0.62  % for dogs attending primary care veterinary 
Open Access
*Correspondence:  linda.heske@nmbu.no 
1 Department of Companion Animal Clinical Sciences, Faculty 
of Veterinary Medicine Biosciences, Norwegian University of Life Sciences, 
P.B. 8146 Dep, 0033 Oslo, Norway
Full list of author information is available at the end of the article
Page 2 of 7Heske et al. Acta Vet Scand  (2015) 57:75 
clinics in the UK [9]. In a large cohort study of insured 
dogs in Sweden, the incidence rate of epilepsy (including 
both idiopathic and symptomatic cases) was estimated to 
be 18 cases per 10,000 dog-years at-risk counted as time 
from the first insurance date until exiting the database 
[10]. However, the disease prevalence is higher within 
breeds that are predisposed to epilepsy [11–14].
A hereditary component of IE has been described in a 
number of dog breeds, including Labrador Retriever, Bel-
gian Shepherd, Boxer, Hungarian Vizsla, English Springer 
Spaniel, Irish Wolfhound and Border Collie [13, 15–23]. 
Differences in the clinical manifestations of the disease 
have been described both between and within breeds, 
and the phenotype of epilepsy in each breed should 
therefore be reported separately.
Our group has published results from a large cohort 
study of epilepsy among insured Swedish dogs and 
showed that the incidence rate for epilepsy in the Rott-
weiler breed is above average, and that the risk of prema-
ture death due to epilepsy is high for affected dogs [10]. 
Additionally, veterinary practitioners, as well as Rott-
weiler breeders and owners, in Sweden have noticed that 
the occurrence of epilepsy has seemed to increase in the 
breed over the last decades (www.rottweilerklubben.se). 
Epilepsy appears to be common in Rottweilers, but pub-
lished literature of the phenotypic description of epilepsy 
in this breed is largely lacking.
The aim of this study was to describe the clinical char-
acteristics of epilepsy in the Rottweiler breed.
Methods
Study population
Names, registration numbers in the Swedish or Norwe-
gian Kennel Club (and thereby the pedigrees), and blood 
samples of purebred Rottweilers with epileptic seizures, 
living in Sweden and Norway, were collected between 
2007 and 2013, in collaboration with the Swedish Rott-
weiler Club, the Swedish University of Agricultural Sci-
ences and the Norwegian University of Life Sciences. The 
study was approved by the local Animal Ethics Commit-
tee in Uppsala (no. C138/6 and no. C139/9). The project 
was announced in the Swedish Veterinary Journal, the 
Journal of the Swedish Rottweiler Club, and at meet-
ings for breeders and owners. Dogs were recruited from 
breeders and veterinary clinics all over Sweden, and to a 
lesser extent Norway, on a volunteer basis. Information 
to the owners was available in the Journal of the Swedish 
Rottweiler Club and online (http://hunddna.slu.se). Bio-
bank consent forms (signed by the dog owners, allow-
ing us to publish the information recorded and obtain 
blood samples from their dog for future research) and a 
questionnaire enquiring about their dog’s health could 
be downloaded directly from the website. Owners of 
dogs that had a diagnosis of epilepsy of unknown origin, 
and opted to participate in the study, made an appoint-
ment with their local veterinarian to have blood-samples 
drawn and to be included in the study.
Questionnaire
Questionnaires were used to record detailed informa-
tion about the dogs’ health (Additional file  1) and were 
completed by the owners when their dogs were blood 
sampled at the veterinary clinic. Questions about the 
dogs included signalment, pedigree, housing conditions 
and information about the seizures such as age at onset, 
seizure type, duration, and progression, as well as num-
ber of seizure days (24 h). Several seizures per day (24 h) 
were counted as one seizure day/one event), effect and 
side effects of anti-epileptic drugs, and potential comor-
bidities. It was possible to select more than one answer 
for many of the questions and not all owners responded 
to all questions. Owners also reported information about 
other diseases and the diagnostic work-up performed at 
the time of the initial diagnosis.
The diagnosis of epilepsy was based primarily on the 
answers to the detailed questionnaires, supplied with 
medical records when available. All dogs in this study met 
the following inclusion criteria for epilepsy of unknown 
origin: ≥2 seizure days, starting between 6  months and 
7 years of age, no known history of poisoning or serious 
head trauma, and (when available), pre-study routine 
serum biochemical parameters were within the refer-
ence intervals. Dogs with sufficient follow-up time (≥4 
months) without progression or a diagnosis of sympto-
matic epilepsy could be classified as suffering from IE. 
Some of the dogs included in this study had a follow-up 
time of less than 4 months; hence, not all dogs included 
fulfilled the criteria for IE.
Serum samples
Serum samples were stored at −80  °C until analysed at 
the Central Laboratory at the Norwegian University of 
Life Sciences. A full serum biochemical profile was per-
formed, including: aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), alkaline phosphatase 
(ALP), creatine kinase (CK), amylase (AMY), lipase (LIP), 
C-reactive protein (CRP), total protein (TP), albumin 
(Alb), globulin (Glob), urea, creatinine (Crea), bile acids, 
total bilirubin (T bili), cholesterol (Chol), inorganic phos-
phorus, calcium (Ca), sodium (Na), potassium (K), Na/K 
ratio, chloride (Cl), and a thyroid profile (TT4, FT4, and 
TSH).
Pedigree analysis
All but one case were purebred Rottweilers registered in 
the Swedish or Norwegian Kennel Clubs. The last dog 
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was not registered, but both its parents were registered in 
the Swedish Kennel Club. The pedigrees of affected dogs 
were assessed to identify common ancestors.
Results
Descriptive statistics
Study population
A total of 37 cases (23 females and 14 males) were 
included in this study. All of the dogs were living indoors 
with their owners as family members, rather than in 
outdoor kennels or in separate doghouses. 16 of the 
dogs were active working dogs, implying that they were 
trained to compete in obedience, tracking, searching, 
or were patrol dogs in the Swedish army. Median body-
weight was 42 kg (range 31–60 kg). Ten of the dogs were 
neutered surgically; two additional dogs were chemi-
cally neutered. Most of the dogs were characterised by 
their owners as active (27), friendly (31) and calm (14) 
by nature. A few dogs were characterised as nervous (5), 
shy (1) or aggressive (3). It was possible to choose several 
options to describe each dog.
Seizure database
The median age at onset of seizures was 36  months 
(range 8–84  months), seemingly with two peaks: At 18 
and 36  months of age (Fig.  1). Twenty-three of 37 dogs 
(62.2 %) had their initial seizure by 36 months of age. The 
date of seizure onset was not reported for one dog and 
that dog was therefore excluded from the study. The fol-
low-up time from the initial seizure until study inclusion 
varied from 1 to 60 months with a median follow-up time 
of 10  months. In total, 26/37 (70.3  %) of the included 
dogs had a follow-up time of >4 months without progres-
sion to more serious illness or SE, and these dogs fulfilled 
the criteria for IE. Seizure frequency ranged from several 
seizures per week to one per year.
Thirty-three of 35 (94.3 %) of the dogs appeared to lose 
consciousness during the seizures, and 26/27 (96.3  %) 
did not respond to contact (when the owner called their 
name) during the seizures. The clinical presentations of 
the seizures are summarized in Table 1. The dogs suffered 
from generalized tonic–clonic seizures with the following 
signs; Stiffness in neck and legs, unconsciousness, saliva-
tion, shaking, gazing, falling to the side, muscle twitch-
ing/shivering, chewing, contraction of facial muscles, 
and urination (whereas defecation was uncommon). The 
most common behaviours reported in the postictal phase 
were confusion and disorientation, restlessness and tired-
ness (Table 2).
Twenty of 37 (54 %) of the dogs had experienced cluster 
seizures (>1 seizure in 24 h). The mean number of seizure 
days (24 h), for the time-period included in the question-
naire, was 12.2 seizure days (range 2–67 seizure days). 
Only 24 owners described how the seizure frequency 
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Fig. 1 Owner-reported age at seizure onset in months, for 37 Swed-
ish Rottweilers with epilepsy
Table 1 Owners’ description of  behaviors observed dur-
ing epileptic seizures among 37 Swedish Rottweilers
The numbers of dogs by frequency of manifestation is given in n/N (%). The 
behaviors are ranked by decreasing frequency
Behavior Always Often Seldom Never
Unresponsive/
Unconscious
32/35 (91.3) 1/35 (2.9) 1/35 (2.9) 1/35 (2.9)
Gazing 28/33 (84.8) 2/33 (6.1) – 3/33 (9.1)
Stiffness in neck and 
legs
30/36 (83.3) 4/36 (11.1) 1/36 (2.8) 1/36 (2.8)
Falling to one side 28/34 (82.3) 2/34 (5.9) – 4/34 (11.8)
Salivating 28/36 (77.8) 3/36 (8.3) 1/36 (2.8) 4/36 (11.1)
Shaking 27/36 (75.0) 4/36 (11.1) 1/36 (2.8) 4/36 (11.1)
Muscle shivering 26/35 (74.3) 3/35 (8.6) 2/35 (5.7) 4/35 (11.4)
Contracting facial 
muscles
19/31 (61.3) 1/31 (3.2) 1/31 (3.2) 10/31 (32.3)
Chewing 18/34 (52.9) 4/34 (11.8) 3/34 (8.8) 9/34 (26.5)
Dilated pupils 13/28 (46.4) 3/28 (10.7) 1/28 (3.6) 11/28 (39.3)
Interacting with 
people
13/30 (43.3) 3/30 (10.0) – 14/30 (46.7)
Dark in eyes 11/27 (40.7) 4/27 (14.8) 1/27 (3.7) 11/27 (40.7)
Changing body 
position
12/31 (38.7) 3/31 (9.7) – 16/31 (51.6)
Anxious/fearsome 12/31 (38.7) 3/31 (9.7) 1/31 (3.2) 15/31 (48.4)
Disoriented 13/34 (38.2) 6/34 (17.7) 5/34 (14.7) 10/34 (29.4)
Turning head to one 
side
12/32 (37.5) 2/32 (6.2) 3/32 (9.4) 15/32 (46.9)
Urinating 10/33 (30.3) 11/33 (33.3) 4/33 (12.1) 8/33 (24.3)
Occasional apnea 9/31 (29.0) 2/31 (6.5) 3/31 (9.7) 17/31 (54.8)
Occasional blindness8/31 (25.8) 3/31 (9.7) 1/31 (3.2) 19/31 (61.3)
Nystagmus 6/30 (20.0) 6/30 (20.0) 2/30 (6.7) 16/30 (53.3)
Barking 5/31 (16.1) – – 26/31 (83.9)
Aggressive 3/31 (9.7) – 3/31 (9.7) 25/31 (80.6)
Walking in circles 2/30 (6.7) 1/30 (3.3) 3/30 (10.0) 24/30 (80.0)
Defecating 2/30 (6.7) – 6/30 (20.0) 22/30 (73.3)
Chasing tail – 3/30 (10.0) 2/30 (6.7) 25/30 (83.3)
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changed over time, (independently of antiepileptic medi-
cation): For 8/24 (33.3 %) of the dogs the frequency had 
decreased, for 11/24 (45.8  %) the frequency was stable, 
and for the remaining 5/24 (20.8  %) the frequency had 
increased. For 19/32 (54.9  %) of the dogs, the duration 
and intensity of the seizures remained the same, while it 
had increased for 5/32 (15.6 %), and decreased for 8/32 
(25  %). The changes in seizure frequency, and intensity 
and duration of the seizures were based on the owners’ 
assessment. The dogs commonly started to seizure while 
resting (23/36) or sleeping (20/36). Only three of the 36 
dogs (8.3  %) experienced seizures during activities such 
as walking or training. For the females, five of 23 bitches 
tended to have seizures around the time of heat; two dur-
ing heat, and three within 2 months after heat. One male 
dog was reported to have more frequent seizures when 
there were females in heat in the neighbourhood.
Thirty of 37 (81.1  %) of the dogs were considered 
normal by the owner between seizures (the inter-ictal 
phase). Of the remaining dogs, five of seven were on phe-
nobarbital and showed behavioural changes most con-
sistent with effects of the antiepileptic medications, such 
as ataxia and sedation. One of the dogs on antiepileptic 
medications was reported to be restless and anxious in a 
way that it had not been previously, during the inter-ictal 
phase. The two dogs that were not on medication were 
both reported to be more apprehensive and irritated than 
before the seizures started.
Diagnostic work‑up in the field
Most of the dogs diagnosed with epilepsy (35/37) pre-
sented to a veterinarian because of the seizures. The 
diagnostic evaluation included haematology and a serum 
biochemical profile (32/37), and further investigations 
performed for some of the dogs included cerebrospinal 
fluid (CSF) analysis (n = 1), magnetic resonance imaging 
(MRI) (n = 2), computed tomography (CT) (n = 1), and 
abdominal ultrasound (n = 5).
Other diseases
Six of 37 (16.2 %) dogs in this study had been treated for 
other diseases: sub aortic stenosis (n =  1; diagnosed as 
puppy and receiving treatment with a β-blocker), cra-
nial cruciate ligament rupture (n = 3; receiving NSAIDs 
(nonsteroidal anti-inflammatory drugs) (for pain relief )), 
and hypothyroidism (n = 2; supplemented with levothy-
roxine). None of dogs diagnosed with epilepsy had sus-
tained brain injuries resulting in loss of consciousness 
during their lifetime. None of the dogs for which infor-
mation about the neonate period was available (n = 15) 
received intensive care or help from the breeder to sur-
vive the paediatric period.
Antiepileptic treatment
Fourteen of the dogs were not on any antiepileptic medi-
cation at the time of data collection; because of infre-
quent seizures, newly diagnosed disease or the owners’ 
concern for potential side-effects of the antiepileptic 
treatment. Twenty-four dogs received phenobarbital, 
and five of these received add-on treatments: potassium 
bromide and levetiracetam (n =  1), potassium bromide 
(n = 3), or imepitoin (n = 1). The median time from sei-
zure onset to initiation of antiepileptic drugs was 36 days 
(range: 1–730  days); 90  % of the dogs were on medica-
tion within 6  months from seizure onset. Serum phe-
nobarbital levels were monitored in 15/24 (62.5  %) of 
the treated dogs. Following initiation of antiepileptic 
treatment, the seizure frequency decreased for 15/21 
(71.4 %) of the dogs, but for 6/21 (28.6 %) the seizure fre-
quency increased. Only 8/18 (44.4  %) dogs experienced 
less severe or shorter seizures after initiation of medi-
cal therapy (data was missing for remaining dogs due to 
short treatment time). The most common side effects of 
the antiepileptic drugs were polyphagia (7/21), polydip-
sia (7/21), exercise intolerance (7/21), reduced ability to 
focus (6/21), sedation (6/21), and ataxia (5/21). Reduced 
working ability was reported as a side effect by the own-
ers of 8/21 (38.1  %) of the dogs. Seven of the treated 
dogs reported no side effects of antiepileptic medica-
tions. Only six dogs were administered additional rectal 
diazepam, during seizures. Three owners gave their dogs 
dietary supplements such as cobalamin and magnesium. 
Seven dogs were neutered after the onset of seizures, but 
none of these experienced reduced seizure frequency or 
intensity after the procedure. Three dogs were eutha-
nized before the time-period of 4 months, due to severe 
seizures, poor seizure control and severe side effects of 
Table 2 Owner description of how 37 Rottweilers with epi-
lepsy mostly behave directly after seizures
The numbers of dogs are given in n/N (%). (The response rate varied and it was 
possible to choose several options)
Behavior Number of dogs/total number (%)
Seem confused/disoriented 26/27 (96.3)
Restless 27/30 (90.0)
Seem to be tired 22/29 (75.9)
Drinking 18/27 (66.7)
Eating 14/27 (51.9)
Wants to go out 13/26 (50.0)
Seem to be blind 8/25 (32.0)
Unwilling to rise 6/25 (24.0)
Seem to be aggressive 4/25 (16.0)
Something else 4/30 (13.3)
Vomiting 3/24 (12.5)
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the anti-epileptic medication. One of these owners, with 
small children in the household, also reported that they 
were afraid of their dog’s aggressive behaviour during the 
post-ictal phase.
Laboratory results
Serum from 29 dogs was analysed, for the remaining 9 
cases the serum was unavailable for analysis. Seven of the 
dogs had increased values of urea, Crea, and Glob, and 
12 of the dogs had an increased ALP activity. All remain-
ing serum biochemical values were within the reference 
intervals provided by the laboratory.
Family history and pedigree
All of the 37 dogs in this study had close relatives (sib-
lings, parents, offspring) or second-degree relatives 
(grandparents, cousins) with epilepsy and 22/37 (59.5 %) 
of the dogs shared one common ancestor. This dog was 
used extensively for breeding during 1992–1997, father-
ing almost 300 offspring and grandfathering 850 in Swe-
den only.
Discussion
This retrospective case-series provides the first detailed 
clinical characterisation of epilepsy of unknown origin in 
the Rottweiler breed.
Although the median age at seizure onset was 
36 months in this study, five of the dogs were older than 
5  years of age (60  months) at seizures onset (Fig.  1). 
Age at seizure onset in this study was similar to that 
reported for some breeds with IE: Italian Spinones 
(39  ±  19  months) [24], Hungarian Vizslas (36  months) 
[21] and English Springer Spaniels (36 months) [20], but 
higher than for Australian Shepherds (30 months), Bor-
der Collies (28.4  months) [17] and Bernese Mountain 
dogs (26.5 months) [25].
There was a slight majority of female dogs (1.6:1) 
included in this study, but because the cases were 
recruited based on owners volunteering, no statement 
can be made about sex predominance. Most studies of 
breed-related epilepsy show a male predominance to epi-
lepsy, for instance in the Australian Shepherd [26], Beagle 
[27] Bernese Mountain dog [25], Golden Retriever [28] 
and Keeshond [29]. The Swedish cohort study of the inci-
dence of canine epilepsy also showed a male predomi-
nance across breeds (male to female ratio: 1.4:1) [10].
According to the study performed by Heske et al. [10], 
the incidence rate of epilepsy in the Rottweiler breed 
was 24.3 (95  % confidence interval (CI) 19.5–29.1) per 
10,000 dog-years at-risk, which is higher than the over-
all incidence rate of 18 (95  % CI 18–19) for all breeds. 
The study included IE as well as SE cases, but based on 
a validation study of the same database it was concluded 
that a majority of the cases were idiopathic [30], lend-
ing further support to the impression of a relatively high 
prevalence of a possible idiopathic epilepsy in this breed. 
Heske et  al. [10] further showed that the mortality rate 
from epilepsy in the Rottweiler breed was 21.5 (95 % CI 
16.5–26.5), which is significantly higher than the general 
mortality rate among epileptic dogs of all breeds of 11 
(95 % CI 11–12) [10]. The survival time after a diagnosis 
of epilepsy was similar to other working breeds, such as 
Border Collies and German Shepherds, but significantly 
shorter than for dogs kept solely for companionship, such 
as Poodles, and smaller breeds like Dachshunds and Bor-
der Terriers [10]. The higher mortality rate and shorter 
life expectancy for Rottweilers with epilepsy compared 
to other breeds might be due to the characteristics of the 
disease, inadequate treatment or poor seizure control. 
Furthermore, adverse side effects of anti-epileptic treat-
ment could be a contributing factor, and this is in agree-
ment with the owners’ reports from the questionnaires 
for those dogs that were euthanized. The shorter survival 
time for Rottweilers and other larger breeds could also be 
related to management issues due to the size of the dog.
In our study, 54 % of the dogs had suffered from cluster 
seizures. This is similar to Australian Shepherds with IE, 
where 48 % of the dogs experienced cluster seizures [26], 
but less than in a population of Italian Spinones in the 
UK, where cluster seizures occurred in 85 % [24], and in a 
study of Border Collies with confirmed IE which revealed 
that cluster seizures appeared in 94 % of the cases [17].
Pharmacological resistance, or poor seizure con-
trol (defined as 1 seizure day/month despite adequate 
therapy with at least one anti-epileptic drug; phenobar-
bital with or without add-on treatment) [26], has been 
reported in breeds such as Border Collies [17, 31] and 
Australian shepherds [26]. In our study, the seizure fre-
quency increased for 6/21 (28.6 %) of the dogs, and 10/18 
(55.6  %) of the dogs showed no improvement in terms 
of seizure duration and intensity, following antiepileptic 
treatment.
Seven dogs in this study were neutered after the onset 
of seizures and none of them experienced reduced sei-
zure frequency or intensity after the procedure. This is 
in line with Weissl et al. [26] reporting that 13 dogs were 
neutered after seizure onset and only one dog improved 
in seizure frequency and severity [26]. Results from Mon-
teiro et al. [5] might suggest a potential therapeutic role 
for neutering, due to the fact that entire dogs were more 
likely to have cluster seizures, and with increased fre-
quency [5], but further studies are necessary to elucidate 
this relationship.
The diagnosis of canine epilepsy depends heavily on 
historical information from the owner, including a care-
ful description of seizure semiology. Ideally, in addition, 
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each dog should undergo a complete diagnostic evalua-
tion, including neurological examination, MRI, and CSF 
analysis, to rule out structural brain diseases causing symp-
tomatic forms of epilepsy. The term “Epilepsy of unknown 
origin (EUO)” was recently introduced for a group of dogs 
diagnosed with epilepsy based on a history of seizures, 
in the absence of other medical problems determined by 
unremarkable clinical examination results and routine 
blood analyses [9]. Epileptic dogs with evidence in previ-
ous records of underlying disease that potentially could 
have caused epilepsy, including advanced brain imaging 
abnormalities, were excluded from the EUO group of dogs 
[9]. Due to the retrospective nature of the present study, 
the limited availability of specialists, and the costs of per-
forming advanced diagnostic imaging and further inves-
tigations, the vast majority of dogs have not undergone 
a complete diagnostic evaluation. However, according to 
Armaşu et al. [32], age at seizure onset was highly predictive 
in differentiating dogs with EUO (mean age at seizure onset 
39.8 ± 26.4 months) from epileptic dogs with structural dis-
eases in the brain [32].
Information about epilepsy occurring in close relatives 
is considered important for classification as IE. All dogs 
included in this study had first- or second degree rela-
tives with epilepsy. In addition, to fulfil the criterion of 
IE, the patients had to have an age of onset of ≥6 months 
and ≤7 years, and a follow-up time-period of ≥4 months 
after the first seizure, with no other neurological signs 
developing, consistent with the classification used in a 
previous study [30]. At least 70 % of the dogs included in 
this study most likely suffered from IE, as these had a fol-
low-up time of more than 4 months. There is no reason 
to suspect symptomatic epilepsy in the remaining dogs, 
but due to the limited follow-up time, a diagnosis of IE is 
less certain in these patients.
Some of the serum biochemical parameters (urea, 
Crea, Glob and ALP) were above the reference intervals. 
12 of 28 (42.9 %) dogs had increased levels of ALP. Ten 
of these 12 dogs received phenobarbital, likely explaining 
the increased ALP activity [33], the other two were barely 
above the reference interval. For the remaining parame-
ters, increases may be partially explained by the relatively 
narrow reference intervals of our diagnostic laboratory. 
Using the reference intervals from the published litera-
ture (IRIS guidelines; www.iris-kidney.com) the values 
for 100  % of our dogs would be considered normal for 
Crea and Glob, and 96.6 % for Urea. Also, there is noth-
ing in these serum biochemistry results leading us to 
believe that the dogs suffered from seizures of other rea-
sons than epilepsy.
This study consists of a case-series of Swedish Rot-
tweilers with owner-reported epilepsy. The diagnosis 
is validated against published diagnostic criteria [30] 
based on detailed questionnaires, and the majority of the 
included dogs are believed to suffer from IE. Because the 
dogs were recruited to the study based on owners volun-
teering to participate, the included individuals are likely 
to represent animals with owners that are very focused 
on the disease or actively associated with the breeding 
club. We still consider the described seizure characteris-
tics to be representative of seizures among Swedish Rot-
tweilers in general, although it is possible that those with 
poorer seizure control were not included-as owners of 
such dogs may be less likely to participate.
Conclusion
Rottweilers suffering from epilepsy in this study pre-
sented with generalized tonic–clonic seizures, and their 
response to antiepileptic treatment was variable. More 
than 50  % of the dogs had experienced cluster seizures 
(>1 seizure in 24 h).
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